The publicly traded healthcare company CooperUnternehmen has agreed to pay $ 1.6 billion to acquire the Los Angeles-based company Generate life sciences.
Generating is integrated into CooperSurgical, CooperCompanies’ women’s health and fertility division announced the company. The deal is expected to close and expand in December high investment rates in the life sciences sector seen across the country.
Generate was founded more than 40 years ago to provide reproductive newborn stem cells and related genetic services. The company acquired Australia-based CellCare Group Earlier this summer and also opened a stem cell manufacturing facility in La Jolla, California.
Generate’s brands also include Nabelschnurblutregister, California Cryobank, Donor Egg Bank USA, NW Cryobank, ReadyGen, Kitazato USA, and Donor applicationand has facilities in Tucson, Arizona, New York, Boston, Palo Alto, California, and Rockville, Md.
The company’s services are designed to complement CooperSurgical in both fertility solutions and labor and delivery. And the combined business will provide fertility clinics and healthcare providers with new ways to support patients, the companies said.
“Generate helps families around the world benefit from its industry-leading services that support customers throughout their reproductive journey, from prenatal to afterbirth,” Generate CEO Richard Jennings said in a statement. “In recent years, our company has grown into a global life sciences organization that supports customers who want to build and protect their families.”
CooperCompanies, headquartered in San Ramon, California, is and operates a global medical device company CooperVision.
Gregory Cornfield can be contacted at [email protected].